Hemophilia is an X-linked bleeding disorder, and patients with hemophilia are deficient in a biologically active coagulation factor. This study was designed to combine the efficiency of lentiviral vector transduction techniques with murine adipose tissue-derived stem/stromal cells (mADSCs) as a new method to produce secreted human coagulation factor IX (hFIX) and to treat hemophilia B. mADSCs were transduced with simian immunodeficiency virus (SIV)-hFIX lentiviral vector at multiplicities of infection (MOIs) from 1 to 60, and the most effective dose was at an MOI of 10, as determined by hFIX production. hFIX protein secretion persisted over the 28-day experimental period. Cell sheets composed of lentiviral vector-transduced mADSCs were engineered to further enhance the usefulness of these cells for future therapeutic applications in transplantation modalities. These experiments demonstrated that genetically transduced ADSCs may become a valuable cell source for establishing cell-based gene therapies for plasma protein deficiencies, such as hemophilia.
Get full access to this article
View all access options for this article.
References
1.
Anjos-AfonsoF., SiapatiE.K., BonnetD.2004. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci., 117:5655–5664.
2.
AurichI., MuellerL.P., AurichH.et al.2007. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut, 56:405–415.
3.
BanasA., TerataniT., YamamotoY.et al.2007. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology, 46:219–228.
4.
BlosteinM., CuerquisJ., LandryS.et al.2008. The carboxylation efficiency of the vitamin K-dependent clotting factors: Studies with factor IX. Haemophilia, 14:1063–1068.
5.
Bolton-MaggsP.H., PasiK.J.2003. Haemophilias A and B. Lancet, 361:1801–1809.
6.
ChuahM.K., CollenD., VandendriesscheT.2004. Preclinical and clinical gene therapy for haemophilia. Haemophilia, 10,Suppl. 4:119–125.
7.
CoffinJ.M., HughesS.H., VarmusH.E.1997. The interactions of retroviruses and their hosts. Retroviruses. CoffinJ.M., HughesS.H., VarmusH.E.Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
8.
CoutuD.L., CuerquisJ., El AyoubiR.et al.2011. Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B. Biomaterials, 32:295–305.
9.
DuanB., ChengL., GaoY.et al.2012. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter. Theriogenology, 78:793–802.
10.
FollenziA., BentenD., NovikoffP.et al.2008. Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. J. Clin. Invest., 118:935–945.
11.
GordonF.H., MistryP.K., SabinC.A.et al.1998. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut, 42:744–749.
12.
Haleem-SmithH., DerfoulA., OkaforC.et al.2005. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol. Biotechnol., 30:9–20.
13.
HonjoS., NaritaT., KobayashiR.et al.1990. Experimental infection of African green monkeys and cynomolgus monkeys with a SIVAGM strain isolated from a healthy African green monkey. J. Med. Primatol., 19:9–20.
14.
JinM.J., HuiH., RobertsonD.L.et al.1994. Mosaic genome structure of simian immunodeficiency virus from West African green monkeys. EMBO J., 13:2935–2947.
15.
KasudaS., KuboA., SakuraiY.et al.2008. Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A. J. Thromb. Haemost., 6:1352–1359.
16.
KernS., EichlerH., StoeveJ.et al.2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24:1294–1301.
17.
KikuchiA., OkanoT.2005. Nanostructured designs of biomedical materials: Applications of cell sheet engineering to functional regenerative tissues and organs. J. Control. Release, 101:69–84.
18.
KikuchiJ., MimuroJ., OgataK.et al.2004. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice. J. Gene Med., 6:1049–1060.
19.
KimJ.H., ShinK.H., LiT.Z.et al.2011. Potential of nucleofected human MSCs for insulin secretion. J. Tissue Eng. Regen. Med., 5:761–769.
20.
LeeK.D., KuoT.K., Whang-PengJ.et al.2004. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology, 40:1275–1284.
21.
LiG.B., LuG.X.2009. Gene delivery efficiency in bone marrow-derived dendritic cells: Comparison of four methods and optimization for lentivirus transduction. Mol. Biotechnol., 43:250–256.
22.
LiH., HaurigotV., DoyonY.et al.2011a. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature, 475:217–221.
LinC.N., KaoC.Y., MiaoC.H.et al.2010. Generation of a novel factor IX with augmented clotting activities in vitro and in vivo. J. Thromb. Haemost., 8:1773–1783.
25.
LinK., MatsubaraY., MasudaY.et al.2008. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy, 10:417–426.
26.
LiuT.M., MartinaM., HutmacherD.W.et al.2007. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells, 25:750–760.
27.
MehtaA.K., MajumdarS.S., AlamP.et al.2009. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene, 428:20–24.
28.
MitchellJ.B., McIntoshK., ZvonicS.et al.2006. Immunophenotype of human adipose-derived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24:376–385.
NakajimaT., NakamaruK., IdoE.et al.2000. Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system. Hum. Gene Ther., 11:1863–1874.
31.
NapolitanoM., MarianiG., LapecorellaM.2010. Hereditary combined deficiency of the vitamin K-dependent clotting factors. Orphanet J. Rare Dis., 5:21.
32.
NishidaK., YamatoM., HayashidaY.et al.2004. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N. Engl. J. Med., 351:1187–1196.
33.
ObokataH., YamatoM., TsunedaS.et al.2011. Reproducible subcutaneous transplantation of cell sheets into recipient mice. Nat. Protoc., 6:1053–1059.
34.
OgataK., MimuroJ., KikuchiJ.et al.2004. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy. Gene Ther., 11:253–259.
35.
OhT., PeisterA., OhashiK.et al.2006. Transplantation of murine bone marrow stromal cells under the kidney capsule to secrete coagulation factor VIII. Cell Transplant., 15:637–645.
36.
OhashiK., YokoyamaT., YamatoM.et al.2007. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat. Med., 13:880–885.
37.
OhashiK., TatsumiK., UtohR.et al.2010. Engineering liver tissues under the kidney capsule site provides therapeutic effects to hemophilia B mice. Cell Transplant., 19:807–813.
38.
PeisterA., MelladJ.A., LarsonB.L.et al.2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood, 103:1662–1668.
39.
PipeS.W., HighK.A., OhashiK.et al.2008. Progress in the molecular biology of inherited bleeding disorders. Haemophilia, 14,Suppl. 3:130–137.
40.
ProschS., SteinJ., StaakK.et al.1996. Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. Biol. Chem. Hoppe Seyler, 377:195–201.
41.
SeoM.J., SuhS.Y., BaeY.C.et al.2005. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem. Biophys. Res. Commun., 328:258–264.
42.
ShimizuH., OhashiK., UtohR.et al.2009. Bioengineering of a functional sheet of islet cells for the treatment of diabetes mellitus. Biomaterials, 30:5943–5949.
SimioniP., TormeneD., TogninG.et al.2009. X-linked thrombophilia with a mutant factor IX (factor IX Padua)N. Engl. J. Med., 361:1671–1675.
45.
SugiiS., KidaY., KawamuraT.et al.2010. Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A., 107:3558–3563.
46.
Talens-ViscontiR., BonoraA., JoverR.et al.2006. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J. Gastroenterol., 12:5834–5845.
47.
TatsumiK., OhashiK., KataokaM.et al.2008a. Successful in vivo propagation of factor IX-producing hepatocytes in mice: Potential for cell-based therapy in haemophilia B. Thromb. Haemost., 99:883–891.
48.
TatsumiK., OhashiK., ShimaM.et al.2008b. Therapeutic effects of hepatocyte transplantation on hemophilia B. Transplantation, 86:167–170.
49.
TieJ.K., JinD.Y., StraightD.L.et al.2011. Functional study of the vitamin K cycle in mammalian cells. Blood, 117:2967–2974.
50.
WaltherW., SteinU.2000. Viral vectors for gene transfer: A review of their use in the treatment of human diseases. Drugs, 60:249–271.
51.
WangP.P., WangJ.H., YanZ.P.et al.2004. Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem. Biophys. Res. Commun., 320:712–716.
52.
YamatoM., AkiyamaY., KobayashiJ.et al.2007. Temperature-responsive cell culture surfaces for regenerative medicine with cell sheet engineering. Prog. Polymer Sci., 32:1123–1133.
YukawaH., NoguchiH., OishiK.et al.2009. Cell transplantation of adipose tissue-derived stem cells in combination with heparin attenuated acute liver failure in mice. Cell Transplant., 18:611–618.
55.
ZaragosiL.E., BillonN., AilhaudG.et al.2007. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells, 25:790–797.
56.
ZukP.A., ZhuM., MizunoH.et al.2001. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng., 7:211–228.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
